The CONFORM Pivotal Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1600 participants.
Also called NCT05147792
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 1,600 participants
- Sponsor
- Conformal Medical, Inc
- Registry
-
NCT05147792
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Czechia, France, Georgia, Germany, Uzbekistan
- Registry status
- Suspended
Technical summary
Registry record NCT05147792. Randomized; no masking; primary purpose prevention. Start 2022-05-26 (actual); primary completion 2028-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The CONFORM Pivotal Trial
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Intervention (Device)
- CLAAS
- Intervention (Device)
- WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
- Lead sponsor
- Conformal Medical, Inc
Record details
- Record id
cardio:ct-nct05147792- Content hash
4456d3ee4ea2c5707b5c8336d01ca4fd1778e6f24cf59ebf4619a99c023ae666